Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Lombardo

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Physical Review Letters|November 26, 2019
Measuring Higgs Couplings without Higgs BosonsBrian Henning, Davide Lombardo, Marc Riembau, et al.
Journal of Clinical Medicine|August 12, 2022
Proadrenomedullin in the Management of COVID-19 Critically Ill Patients in Intensive Care Unit: A Systematic Review and Meta-Analysis of Evidence and Uncertainties in Existing LiteratureGiorgia Montrucchio, Eleonora Balzani, Davide Lombardo, et al.
Frontiers in Medicine|April 10, 2023
Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective studyGiorgia Montrucchio, Gabriele Sales, Eleonora Balzani, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Physical Review Letters|November 26, 2019
Measuring Higgs Couplings without Higgs BosonsBrian Henning, Davide Lombardo, Marc Riembau, et al.
Journal of Clinical Medicine|August 12, 2022
Proadrenomedullin in the Management of COVID-19 Critically Ill Patients in Intensive Care Unit: A Systematic Review and Meta-Analysis of Evidence and Uncertainties in Existing LiteratureGiorgia Montrucchio, Eleonora Balzani, Davide Lombardo, et al.
Frontiers in Medicine|April 10, 2023
Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective studyGiorgia Montrucchio, Gabriele Sales, Eleonora Balzani, et al.
Pageof 1